While the concept of providing total biopharmaceutical solutions has historically been present only within the U.S. and certain European countries, nations such as India, Korea, and China have started to adopt the same business model over the past few years, and have attracted big business as a result, thanks to vast differences in production and labor costs in developed and developing countries.